...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Shareholder Value

Both the ZHCLF carry the same CUSIP # as the Zenith Capital Corp shares from the original 2013 spinoff . That is 100% a fact. I have purchased the OTC ZHCLF shares recently and they have been combining with with spin-off shares in the exact same account. No way to differentiate either shares. So IMHO they are the exact shares as the PP shares from exempt distribution just at  a 70 % less cost base to the recent PP Of course DM would try to dissuade or give caution as it doesn't help his PP finance cause . 

Maybe if a proper management team came in with real BP pharma talent they would get the respect in the markets and could put together a similar  IPO as what REPARE therapeutics. DM needs to make some major decisions and new strategies on how to get a proper Enterprise valuation for a company with such high promise in its science . 

 

Share
New Message
Please login to post a reply